www.nytimes.com
1 month agoDigital life
Revenues Down and Stock Battered as Data Firm Faces Scrutiny
MultiPlan faces increased scrutiny due to its controversial billing practices that hit patient expenses while benefitting health insurers.
The company's stock has plummeted by 70% since media investigation revealed its practices. [ more ]